Alogliptin Benzoate is a selective dipeptidyl peptidase-4
(DPP-4) inhibitor in the antidiabetic class. Also known as Alogliptin benzoate
salt. Among gliptins it is known for high DPP-4 selectivity and a stable,
well-characterised salt form that suits solid oral dosage development. ApiSyn
manufactures it in Ahmedabad, India, backed by an active US Type II DMF for
regulated-market filings. ApiSyn also supports customers with NDSRI risk
assessment inputs for this secondary-amine molecule. Related impurity reference
standards can be arranged through SynZeal.
| Chemical Name | (R)-2-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile Benzoate |
| Molecular Formula | C18H21N5O2 : C7H6O2 |
| Molecular Weight | 339.4 : 122.1 |
| CAS Number | 850649-62-6 |